{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:18:30Z","timestamp":1783577910836,"version":"3.55.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T00:00:00Z","timestamp":1751241600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100012112","name":"Swedish Orphan Biovitrum","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012112","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Inflammatix"},{"DOI":"10.13039\/501100023710","name":"Hellenic Institute for the Study of Sepsis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023710","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["ICMx"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>Biomarkers based on host response signatures are currently under development for the critically ill. We applied a 29-mRNA classifier for the diagnosis and prognosis of suspected acute infection and sepsis (TriVerity<jats:sup>\u2122<\/jats:sup>, Inflammatix Inc.) in patients hospitalized with COVID-19.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We applied three scores from locked classifiers (IMX-BVN-4 and IMX-SEV-4) from the 29-mRNA TriVerity<jats:sup>\u2122<\/jats:sup> blood test in participants of the SAVE-MORE randomized clinical trial (ClinicalTrials.gov NCT04680949) at baseline and days 4 and 7 of treatment, to classify bacterial infection, viral infection and decompensation. Participants were adults hospitalized with confirmed COVID-19 pneumonia and plasma soluble urokinase plasminogen activator receptor (suPAR) levels of\u2009\u2265\u20096\u00a0ng\/ml, randomized to placebo or anakinra treatment.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>A total of 471 patients were studied. At baseline nearly 90% had a Very Low or Low IMX-BVN-4 Bacterial Score and Moderate, High or Very High IMX-BVN-4 Viral Score. Anakinra treatment had an effect on the expression of genes indicating IMX-SEV-4 High or Very High scores after a 7\u00a0day treatment compared to baseline (12.9% of anakinra-treated patients continued being classified as high severity vs 20.4% of placebo-treated patients, p 0.046).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusions<\/jats:title>\n            <jats:p>The classifiers were well tested in COVID-19 pneumonia and may become a useful tool for hospitalized patients.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s40635-025-00777-1","type":"journal-article","created":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T03:02:19Z","timestamp":1751252539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial"],"prefix":"10.1186","volume":"13","author":[{"given":"Evdoxia","family":"Kyriazopoulou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antigone","family":"Kotsaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asimina","family":"Safarika","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Garyfallia","family":"Poulakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralampos","family":"Milionis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simeon","family":"Metallidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Adamis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archontoula","family":"Fragkou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aggeliki","family":"Rapti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Del Vecchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioannis","family":"Kalomenidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae","family":"Kitzoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Angheben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Kainis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina","family":"Iliopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco Saverio","family":"Serino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Bakakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Tzavara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Ioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Dagna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katerina","family":"Dimakou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glykeria","family":"Tzatzagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Chini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bassetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Kotsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tsoukalas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Selmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Nikolakopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Samarkos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Doumas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Masgala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Papanikolaou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Argyraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karolina","family":"Akinosoglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Styliani","family":"Symbardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Periklis","family":"Panagopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George N.","family":"Dalekos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Liesenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy E.","family":"Sweeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Purvesh","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4713-3911","authenticated-orcid":false,"given":"Evangelos J.","family":"Giamarellos-Bourboulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,6,30]]},"reference":[{"key":"777_CR1","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1001\/jama.2016.0287","volume":"315","author":"M Singer","year":"2016","unstructured":"Singer M, Deutschman CS, Seymour CW, Shankar-Hari M, Annane D, Bauer M, Bellomo R, Bernard GR, Chiche JD, Coopersmith CM, Hotchkiss RS, Levy MM, Marshall JC, Martin GS, Opal SM, Rubenfeld GD, van der Poll T, Vincent JL, Angus DC (2016) The third international consensus definitions for sepsis and septic shock (Sepsis-3). JAMA 315:801","journal-title":"JAMA"},{"key":"777_CR2","doi-asserted-by":"publisher","first-page":"2042","DOI":"10.1097\/CCM.0000000000005195","volume":"49","author":"E Karakike","year":"2021","unstructured":"Karakike E, Giamarellos-Bourboulis EJ, Kyprianou M, Fleischmann-Struzek C, Pletz MW, Netea MG, Reinhart K, Kyriazopoulou E (2021) Coronavirus disease 2019 as cause of viral sepsis: a systematic review and meta-analysis. Crit Care Med 49:2042","journal-title":"Crit Care Med"},{"key":"777_CR3","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1186\/s13054-020-02993-5","volume":"24","author":"C Pierrakos","year":"2020","unstructured":"Pierrakos C, Velissaris D, Bisdorff M, Marshall JC, Vincent JL (2020) Biomarkers of sepsis: time for a reappraisal. Crit Care 24:287","journal-title":"Crit Care"},{"key":"777_CR4","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1097\/SHK.0000000000001970","volume":"58","author":"A Kostaki","year":"2022","unstructured":"Kostaki A, Wacker JW, Safarika A, Solomonidi N, Katsaros K, Giannikopoulos G, Koutelidakis IM, Hogan CA, Uhle F, Liesenfeld O, Sweeney TE, Giamarellos-Bourboulis EJ (2022) A 29-mRNA host response whole-blood signature improves prediction of 28\u00a0day mortality and 7\u00a0day intensive care unit care in adults presenting to the emergency department with suspected acute infection and\/or sepsis. Shock 58:224","journal-title":"Shock"},{"key":"777_CR5","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000005027","volume":"49","author":"S Thair","year":"2021","unstructured":"Thair S, Mewes C, Hinz J, Bergmann I, B\u00fcttner B, Sehmisch S, Meissner K, Quintel M, Sweeney TE, Khatri P, Mansur A (2021) Gene expression-based diagnosis of infections in critically Ill patients-prospective validation of the SepsisMetaScore in a longitudinal severe trauma cohort. Crit Care Med 49:e751","journal-title":"Crit Care Med"},{"key":"777_CR6","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2022.21520","volume":"5","author":"SC Brakenridge","year":"2022","unstructured":"Brakenridge SC, Chen UI, Loftus T, Ungaro R, Dirain M, Kerr A, Zhong L, Bacher R, Starostik P, Ghita G, Midic U, Darden D, Fenner B, Wacker J, Efron PA, Liesenfeld O, Sweeney TE, Moldawer LL (2022) Evaluation of a multivalent transcriptomic metric for diagnosing surgical sepsis and estimating mortality among critically Ill patients. JAMA Netw Open 5:e2221520","journal-title":"JAMA Netw Open"},{"key":"777_CR7","doi-asserted-by":"publisher","DOI":"10.1128\/spectrum.02305-22","volume":"10","author":"N Ram-Mohan","year":"2022","unstructured":"Ram-Mohan N, Rogers AJ, Blish CA, Nadeau KC, Zudock EJ, Kim D, Quinn JV, Sun L, Liesenfeld O, Stanford COVID-19 Biobank Study Group, Yang S (2022) Using a 29-mRNA host response classifier to detect bacterial coinfections and predict outcomes in COVID-19 patients presenting to the emergency department. Microbiol Spectr 10:e0230522","journal-title":"Microbiol Spectr"},{"key":"777_CR8","doi-asserted-by":"publisher","first-page":"ofac437","DOI":"10.1093\/ofid\/ofac437","volume":"9","author":"W Bauer","year":"2022","unstructured":"Bauer W, Gl\u00e4ser S, Thiemig D, Wanner K, Peric A, Behrens S, Bialas J, Behrens A, Galtung N, Liesenfeld O, Sun L, May L, Mace S, Ott S, Vesenbeckh S (2022) Detection of viral infection and bacterial coinfection and superinfection in coronavirus disease 2019 patients presenting to the emergency department using the 29-mRNA host response classifier IMX-BVN-3: a multicenter study. Open Forum Infect Dis 9:ofac437","journal-title":"Open Forum Infect Dis"},{"key":"777_CR9","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41591-021-01499-z","volume":"27","author":"E Kyriazopoulou","year":"2021","unstructured":"Kyriazopoulou E, Poulakou G, Milionis H, Metallidis S, Adamis G, Tsiakos K, Fragkou A, Rapti A, Damoulari C, Fantoni M, Kalomenidis I, Chrysos G, Angheben A, Kainis I, Alexiou Z, Castelli F, Serino FS, Tsilika M, Bakakos P, Nicastri E, Tzavara V, Kostis E, Dagna L, Koufargyris P, Dimakou K, Savvanis S, Tzatzagou G, Chini M, Cavalli G, Bassetti M, Katrini K, Kotsis V, Tsoukalas G, Selmi C, Bliziotis I, Samarkos M, Doumas M, Ktena S, Masgala A, Papanikolaou I, Kosmidou M, Myrodia DM, Argyraki A, Cardellino CS, Koliakou K, Katsigianni EI, Rapti V, Giannitsioti E, Cingolani A, Micha S, Akinosoglou K, Liatsis-Douvitsas O, Symbardi S, Gatselis N, Mouktaroudi M, Ippolito G, Florou E, Kotsaki A, Netea MG, Eugen-Olsen J, Kyprianou M, Panagopoulos P, Dalekos GN, Giamarellos-Bourboulis EJ (2021) Early treatment of COVID-19 with anakinra guided by soluble urokinase plasminogen receptor plasma levels: a double-blind, randomized controlled phase 3 trial. Nat Med 27:1752","journal-title":"Nat Med"},{"key":"777_CR10","unstructured":"European Medicines Agency (2021). EMA recommends approval for use of Kineret in adults with COVID-19. https:\/\/www.ema.europa.eu\/en\/news\/ema-recommends-approval-use-kineret-adults-covid-19."},{"key":"777_CR11","unstructured":"Fact sheet for healthcare providers: emergency use authorization for Kineret. https:\/\/www.fda.gov\/media\/163075\/download."},{"key":"777_CR12","unstructured":"World Health Organization. Clinical management of COVID-19: living guideline. 2023. https:\/\/www.who.int\/publications\/i\/item\/WHO-2019-nCoV-clinical-2023.1."},{"key":"777_CR13","doi-asserted-by":"publisher","first-page":"1177","DOI":"10.1038\/s41467-020-14975-w","volume":"11","author":"MB Mayhew","year":"2020","unstructured":"Mayhew MB, Buturovic L, Luethy R, Midic U, Moore AR, Roque JA, Shaller BD, Asuni T, Rawling D, Remmel M, Choi K, Wacker J, Khatri P, Rogers AJ, Sweeney TE (2020) A generalizable 29-mRNA neural-network classifier for acute bacterial and viral infections. Nat Commun 11:1177","journal-title":"Nat Commun"},{"key":"777_CR14","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3390\/jpm10040266","volume":"10","author":"J Ducharme","year":"2020","unstructured":"Ducharme J, Self WH, Osborn TM, Ledeboer NA, Romanowsky J, Sweeney TE, Liesenfeld O, Rothman RE (2020) A multi-mRNA host-response molecular blood test for the diagnosis and prognosis of acute infections and sepsis: proceedings from a clinical advisory panel. J Person Med 10:266","journal-title":"J Person Med"},{"key":"777_CR15","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1097\/CCM.0000000000005119","volume":"49","author":"W Bauer","year":"2020","unstructured":"Bauer W, Kappert K, Galtung N, Lehmann D, Wacker J, Cheng HK, Liesenfeld O, Buturovic L, Luethy R, Sweeney TE, Tauber R, Somasundaram R (2020) A novel 29-mRNA host response assay from whole blood accurately identifies bacterial and viral infections in patients presenting to the emergency department with suspected infections: a prospective observational study. Crit Care Med 49:1664","journal-title":"Crit Care Med"},{"key":"777_CR16","first-page":"357","volume":"29","author":"N Galtung","year":"2022","unstructured":"Galtung N, Diehl-Wiesenecker E, Lehmann D, Markmann N, Bergstr\u00f6m WH, Wacker J, Liesenfeld O, Mayhew M, Buturovic L, Luethy R, Sweeney TE, Tauber R, Kappert K, Somasundaram R, Bauer W (2022) Prospective validation of a transcriptomic severity classifier among patients with suspected acute infection and sepsis in the emergency department. Eur J Emerg Med 29:357","journal-title":"Eur J Emerg Med"},{"key":"777_CR17","unstructured":"(k) substantial equivalence determination decision summary. Assay and instrument. https:\/\/www.accessdata.fda.gov\/cdrh_docs\/reviews\/K241676.pdf."},{"key":"777_CR18","unstructured":"Proceedings of machine learning research. Development of machine learning classifiers for blood-based diagnosis and prognosis of suspected acute infections and sepsis. https:\/\/proceedings.mlr.press\/v259\/buturovic25a.html."},{"key":"777_CR19","unstructured":"Rapid and accurate diagnosis and prognosis of acute infections and sepsis from whole blood using host response mRNA amplification and result interpretation by Machine-Learning Classifiers. https:\/\/www.researchsquare.com\/article\/rs-5194992\/v1."},{"key":"777_CR20","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1186\/s40635-021-00394-8","volume":"9","author":"A Safarika","year":"2021","unstructured":"Safarika A, Wacker JW, Katsaros K, Solomonidi N, Giannikopoulos G, Kotsaki A, Koutelidakis IM, Coyle SM, Cheng HK, Liesenfeld O, Sweeney TE, Giamarellos-Bourboulis EJ (2021) A 29-mRNA host response test from blood accurately distinguishes bacterial and viral infections among emergency department patients. Intensiv Care Med Exp 9:31","journal-title":"Intensiv Care Med Exp"},{"key":"777_CR21","doi-asserted-by":"publisher","DOI":"10.1111\/eci.13957","volume":"53","author":"M Shojaei","year":"2023","unstructured":"Shojaei M, Chen UI, Midic U, Thair S, Teoh S, McLean A, Sweeney TE, Thompson M, Liesenfeld O, Khatri P, Tang B (2023) Multisite validation of a host response signature for predicting likelihood of bacterial and viral infections in patients with suspected influenza. Eur J Clin Invest 53:e13957","journal-title":"Eur J Clin Invest"},{"key":"777_CR22","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.immuni.2021.03.002","volume":"54","author":"H Zheng","year":"2021","unstructured":"Zheng H, Rao AM, Dermadi D, Toh J, Murphy Jones L, Donato M, Liu Y, Su Y, Dai CL, Kornilov SA, Karagiannis M, Marantos T, Hasin-Brumshtein Y, He YD, Giamarellos-Bourboulis EJ, Heath JR, Khatri P (2021) Multi-cohort analysis of host immune response identifies conserved protective and detrimental modules associated with severity across viruses. Immunity 54:753-768.e5","journal-title":"Immunity"},{"key":"777_CR23","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1093\/cid\/ciaa530","volume":"71","author":"TM Rawson","year":"2020","unstructured":"Rawson TM, Moore LSP, Zhu N, Ranganathan N, Skolimowska K, Gilchrist M, Satta G, Cooke G, Holmes A (2020) Bacterial and fungal coinfection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing. Clin Infect Dis 71:2459","journal-title":"Clin Infect Dis"},{"key":"777_CR24","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0251170","volume":"16","author":"JS Musuuza","year":"2021","unstructured":"Musuuza JS, Watson L, Parmasad V, Putman-Buehler N, Christensen L, Safdar N (2021) Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE 16:e0251170","journal-title":"PLoS ONE"},{"key":"777_CR25","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1186\/s13054-020-03291-w","volume":"24","author":"M van Berkel","year":"2020","unstructured":"van Berkel M, Kox M, Frenzel T, Pickkers P, Schouten J, RCI-COVID-19 study group (2020) Biomarkers for antimicrobial stewardship a reappraisal in COVID-19 times? Crit Care 24:600","journal-title":"Crit Care"},{"key":"777_CR26","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1186\/s13054-021-03717-z","volume":"25","author":"EJ Kooistra","year":"2021","unstructured":"Kooistra EJ, van Berkel M, van Kempen NF, van Latum CRM, Bruse N, Frenzel T, van den Berg MJW, Schouten JA, Kox M, Pickkers P (2021) Dexamethasone and tocilizumab treatment considerably reduces the value of C-reactive protein and procalcitonin to detect secondary bacterial infections in COVID-19 patients. Crit Care 25:281","journal-title":"Crit Care"},{"key":"777_CR27","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1007\/s00134-022-06769-z","volume":"48","author":"RA Lukaszewski","year":"2022","unstructured":"Lukaszewski RA, Jones HE, Gersuk VH, Russell P, Simpson A, Brealey D, Walker J, Thomas M, Whitehouse T, Ostermann M, Koch A, Zacharowski K, Kruhoffer M, Chaussabel D, Singer M (2022) Presymptomatic diagnosis of postoperative infection and sepsis using gene expression signatures. Intensiv Care Med 48:1133","journal-title":"Intensiv Care Med"},{"key":"777_CR28","doi-asserted-by":"publisher","first-page":"1141","DOI":"10.1038\/s41591-022-01843-x","volume":"28","author":"DM Maslove","year":"2022","unstructured":"Maslove DM, Tang B, Shankar-Hari M, Lawler PR, Angus DC, Baillie JK, Baron RM, Bauer M, Buchman TG, Calfee CS, Dos Santos CC, Giamarellos-Bourboulis EJ, Gordon AC, Kellum JA, Knight JC, Leligdowicz A, McAuley DF, McLean AS, Menon DK, Meyer NJ, Moldawer LL, Reddy K, Reilly JP, Russell JA, Sevransky JE, Seymour CW, Shapiro NI, Singer M, Summers C, Sweeney TE, Thompson BT, van der Poll T, Venkatesh B, Walley KR, Walsh TS, Ware LB, Wong HR, Zador ZE, Marshall JC (2022) Redefining critical illness. Nat Med 28:1141","journal-title":"Nat Med"},{"key":"777_CR29","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1164\/rccm.202311-2086SO","volume":"210","author":"AC Gordon","year":"2024","unstructured":"Gordon AC, Alipanah-Lechner N, Bos LD, Dianti J, Diaz JV, Finfer S, Fujii T, Giamarellos-Bourboulis EJ, Goligher EC, Gong MN, Karakike E, Liu VX, Lumlertgul N, Marshall JC, Menon DK, Meyer NJ, Munroe ES, Myatra SN, Ostermann M, Prescott HC, Randolph AG, Schenck EJ, Seymour CW, Shankar-Hari M, Singer M, Smit MR, Tanaka A, Taccone FS, Thompson BT, Torres LK, van der Poll T, Vincent JL, Calfee CS (2024) From ICU syndromes to ICU subphenotypes: consensus report and recommendations for developing precision medicine in the ICU. Am J Respir Crit Care Med 210:155","journal-title":"Am J Respir Crit Care Med"},{"key":"777_CR30","doi-asserted-by":"publisher","first-page":"934","DOI":"10.1097\/CCM.0000000000002402","volume":"45","author":"TE Sweeney","year":"2017","unstructured":"Sweeney TE, Khatri P (2017) Generalizable biomarkers in critical care: toward precision medicine. Crit Care Med 45:934","journal-title":"Crit Care Med"},{"key":"777_CR31","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1186\/s13054-020-02897-4","volume":"24","author":"N Rovina","year":"2020","unstructured":"Rovina N, Akinosoglou K, Eugen-Olsen J, Hayek S, Reiser J, Giamarellos-Bourboulis EJ (2020) Soluble urokinase plasminogen activator receptor (suPAR) as an early predictor of severe respiratory failure in patients with COVID-19 pneumonia. Crit Care 24:187","journal-title":"Crit Care"}],"container-title":["Intensive Care Medicine Experimental"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00777-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40635-025-00777-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40635-025-00777-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,30]],"date-time":"2025-06-30T03:02:22Z","timestamp":1751252542000},"score":1,"resource":{"primary":{"URL":"https:\/\/icm-experimental.springeropen.com\/articles\/10.1186\/s40635-025-00777-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,30]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["777"],"URL":"https:\/\/doi.org\/10.1186\/s40635-025-00777-1","relation":{},"ISSN":["2197-425X"],"issn-type":[{"value":"2197-425X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,30]]},"assertion":[{"value":"12 January 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The SAVE-MORE trial (NCT04680949) was approved by the National Ethics Committee of Greece (approval 161\/20) and by the Ethics Committee of the National Institute for Infectious Diseases Lazzaro Spallanzani, IRCCS, in Rome (1 February 2021). All patients or their legal representatives provided written informed consent before enrollment.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"TS is an employee of and shareholder in Inflammatix, Inc. OL and PK are shareholders in Inflammatix, Inc. EJG-B reports honoraria from Abbott Products Operations, bioM\u00e9rieux, Brahms GmbH, GSK, InflaRx GmbH, Sobi and Xbiotech Inc; independent educational grants from Abbott Products Operations, bioM\u00e9rieux Inc, Johnson & Johnson, MSD, UCB, Swedish Orphan Biovitrum AB; and funding from the Horizon 2020 European Grants ImmunoSep and RISCinCOVID and the Horizon Health grants EPIC-CROWN-2, POINT and Homi-Lung (granted to the Hellenic Institute for the Study of Sepsis). The other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"67"}}